35.82
Crinetics Pharmaceuticals Inc (CRNX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
4,208%
6.161
|
0.143 | 1.031 | 0.361 | - |
| Operating Expenses |
2.79%
138.75
|
142.73 | 130.14 | 111.77 | 87.80 |
| Benefits Costs and Expenses |
1.10%
128.80
|
130.23 | - | - | - |
| Costs And Expenses |
38.54%
180.43
|
130.23 | 130.14 | 111.77 | 87.80 |
| Depreciation and Amortization |
1.78%
0.994
|
1.012 | 0.959 | 0.925 | 0.77 |
| Operating Income/Loss |
6.26%
-133.67
|
-142.59 | -129.11 | -111.41 | -87.80 |
| Nonoperating Income/Loss |
11.72%
11.03
|
12.49 | 13.47 | 14.63 | 10.97 |
| Income/Loss Before Equity Method Investments |
5.73%
-122.64
|
-130.09 | - | - | - |
| Income/Loss From Equity Method Investments |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
5.73%
-122.64
|
-130.09 | 1.031 | 0.361 | -76.83 |
| Income/Loss From Continuing Operations After Tax |
5.59%
-122.81
|
-130.09 | -115.64 | -96.77 | -76.83 |
|
|
5.59%
-122.81
|
-130.09 | -115.64 | -96.77 | -76.83 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.63%
0.35
|
94.22 | 93.79 | 93.10 | 80.09 |
| Diluted Average Shares |
99.63%
0.35
|
94.22 | 93.79 | 93.10 | 80.09 |
| Basic Earnings Per Share |
6.52%
-1.29
|
-1.38 | -1.23 | -1.04 | -0.96 |
| Diluted Earnings Per Share |
6.52%
-1.29
|
-1.38 | -1.23 | -1.04 | -0.96 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):